The present research revealed that the use of albumin was linked to increased in-hospital mortality rates, and extended hospital and ICU stays compared to patients not receiving albumin, particularly among heart failure patients with hypoalbuminemia. This evidence concerns the gene ALB and Hypoalbuminemia.